Where does Kostas Kaloulis work?

Kostas Kaloulis is Venture Partner at +ND Capital.

Kostas Kaloulis

Investor

Venture Partner at +ND Capital

Lausanne

Find your path to Kostas

138 people in our graph share verified history with Kostas — schools, employers, funds. One of them is your warm intro.

Dave BarrettunlockedKostas: together at Dana-Farber Cancer Institute (2022–2026)

×6Kostas: together at Dana-Farber Cancer Institute

×3Kostas: together at Merck Serono

×2Kostas: together at Innosuisse - Schweizerische Agentur für Innovationsförderung

About

Kostas joined +ND Capital's Lausanne office in 2018 and is CEO of EVIR Therapeutics, having spun out companies from EPFL and the University of Bern. He holds a PhD in Molecular Embryology.

Contact· self-published, not guessed

k•••@nd.capitalreveal

Experience

+ND CapitalVenture Partnercurrent2018 — presentSwitzerland
Dana-Farber Cancer InstituteBusiness Council at Dana-Farber Innovations, Membercurrent2022 — present
Avrion TherapeuticsCo Founder and Board membercurrent2020 — present
EVIR TherapeuticsChief Executive Officer and Board membercurrent2020 — present
ReMedysCo-Founder & Board Membercurrent2013 — presentGeneva, Geneva, Switzerland
PulseSight TherapeuticsBoard Membercurrent2024 — presentParis, Île-de-France, France
EpiCure BiotechnologiesChief Executive Officer and Board member2023 — 2025Switzerland
Arctos Medical/Acquired by NovartisChief Executive Officer, co founder and Board member/Acquired by Novartis2020 — 2021Switzerland
Innosuisse - Schweizerische Agentur für InnovationsförderungInnosuisse, Swiss Confederation Innovation Agency, Expert Startups2018 — 2020Switzerland
LifeCare PartnersBusiness Development & Entrepreneur in Residence2013 — 2016Basel, Basel, Switzerland
Merck SeronoDirector, Business Development, Strategic Innovation & Strategic Partnerships2010 — 2013Geneva, Geneva, Switzerland
Merck SeronoAssociate Director, Strategic Innovation and Partnerships Management2007 — 2010Geneva, Geneva, Switzerland

Skills & more

Non-profit ManagementStart-ups ManagementInvestingBoard GovernanceStrategic PartnershipsBusiness DevelopmentCell TherapyGene TherapyDrug DevelopmentMergers & Acquisitions (M&A)Licensing NegotiationsFundraising

+9 more

InvestmentsStart-up VenturesExecutive ManagementCEOsBoard of DirectorsStartupsGene and Cell therapyinvestment agreementsStrategy

From Kostas's professional profile.

Colleagues at +ND Capital

Aditya Rajagopal

Venture Partner at +ND Capital

Alison Palmer

Vice President of the General Partner at +ND Capital

André Châtelain

Advisor at +ND Capital

Aymeric Sallin

Founder and CEO at +ND Capital

Carl Pabo

Advisor at +ND Capital

Cathleen O’Connor

Executive Assistant at +ND Capital

Eric Moessinger

Partner at +ND Capital

Gabriela Ecco

Principal at +ND Capital

Frequently asked questions

Who is Kostas Kaloulis?: Kostas joined +ND Capital's Lausanne office in 2018 and is CEO of EVIR Therapeutics, having spun out companies from EPFL and the University of Bern. He holds a PhD in Molecular Embryology.
Where does Kostas Kaloulis work?: Kostas Kaloulis is Venture Partner at +ND Capital.